Aravive, Inc. (ARAV) financial statements (2021 and earlier)

Company profile

Business Address RIVER OAKS TOWER
HOUSTON, TX 77098
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments61655781201182171
Cash and cash equivalents61655781201182171
Receivables 31    
Prepaid expense1100322
Other undisclosed current assets0000110
Total current assets:62685882205185173
Noncurrent Assets
Operating lease, right-of-use asset39
Property, plant and equipment1201001
Intangible assets, net (including goodwill)000    
Intangible assets, net (excluding goodwill)000    
Other noncurrent assets010  01
Other undisclosed noncurrent assets221111   
Total noncurrent assets:6141112011
TOTAL ASSETS:68826994206185174
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities53261599
Accounts payable3102121
Accrued liabilities21141376
Employee-related liabilities      2
Taxes payable    0  
Deferred revenue3 
Debt 2     
Deferred revenue and credits 40  
Other undisclosed current liabilities2 0   (2)
Total current liabilities:95265597
Noncurrent Liabilities
Long-term debt and lease obligation68     
Operating lease, liability68
Liabilities, other than long-term debt4      
Deferred revenue4 
Other undisclosed noncurrent liabilities 085   
Total noncurrent liabilities:10885   
Total liabilities:201310115597
Stockholders' equity
Stockholders' equity attributable to parent, including:48696083151177167
Common stock0000000
Additional paid in capital549539511457441370279
Accumulated other comprehensive loss    (0)  
Accumulated deficit(501)(470)(451)(374)(289)(193) 
Other undisclosed stockholders' equity attributable to parent      (111)
Total stockholders' equity:48696083151177167
TOTAL LIABILITIES AND EQUITY:68826994206185174

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenue, net40   
Gross profit:65140   
Operating expenses(36)(27)(77)(124)(96)(83)(46)
Operating loss:(31)(22)(75)(84)(96)(83)(46)
Nonoperating income (expense)042(1)10(11)
Investment income, nonoperating0111100
Other nonoperating income (expense)(0)31(2)00(12)
Interest and debt expense  (2)    
Loss from continuing operations before income taxes:(31)(18)(76)(85)(96)(82)(58)
Income tax expense (benefit)   0(0)  
Net loss attributable to parent:(31)(18)(76)(85)(96)(82)(58)
Preferred stock dividends and other adjustments      (26)
Net loss available to common stockholders, diluted:(31)(18)(76)(85)(96)(82)(83)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(31)(18)(76)(85)(96)(82)(58)
Comprehensive loss:(31)(18)(76)(85)(96)(82)(58)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   0(0)  
Comprehensive loss, net of tax, attributable to parent:(31)(18)(76)(85)(96)(82)(58)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: